DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Abraham E, Reinhart K, Svoboda P. et al.
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.
Crit Care Med 2001;
29 (11) 2081-9.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.